By Professor Michael Proinsias Farrell

Journal articles

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'Trends in opioid analgesic utilisation among people with a history of opioid dependence', Drug and Alcohol Dependence, 238, http://dx.doi.org/10.1016/j.drugalcdep.2022.109548

Bharat C; Gisev N; Barbieri S; Dobbins T; Larney S; Farrell M; Degenhardt L, 2022, 'The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.', International Journal of Population Data Science, 7, http://dx.doi.org/10.23889/ijpds.v7i3.1954

McKenna MC; McGovern E; Farrell M; Killeen RP; McGuigan C; Connolly S, 2022, 'Neurogenic muscle hypertrophy following L5 motor radiculopathy', PRACTICAL NEUROLOGY, http://dx.doi.org/10.1136/pn-2022-003461

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Brothers TD; Lewer D; Jones N; Colledge-Frisby S; Farrell M; Hickman M; Webster D; Hayward A; Degenhardt L, 2022, 'Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia', PLoS Medicine, 19, pp. e1004049, http://dx.doi.org/10.1371/journal.pmed.1004049

Colledge-Frisby S; Jones N; Larney S; Peacock A; Lewer D; Brothers TD; Hickman M; Farrell M; Degenhardt L, 2022, 'The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study', Drug and Alcohol Dependence, 236, http://dx.doi.org/10.1016/j.drugalcdep.2022.109494

Hall W; Farrell M, 2022, 'Aldous Huxley's The Doors of Perception', Addiction, 117, pp. 1811 - 1815, http://dx.doi.org/10.1111/add.15713

Nielsen S; Picco L; Murnion B; Winters B; Matheson J; Graham M; Campbell G; Parvaresh L; Khor KE; Betz-Stablein B; Farrell M; Lintzeris N; Le Foll B, 2022, 'Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies', Neuropsychopharmacology, 47, pp. 1315 - 1330, http://dx.doi.org/10.1038/s41386-022-01322-4

Klaas KM; Fischer PR; Segner S; Tsai Owens M; Fahrenkamp A; Geske J; Hofschulte D; Farrell M; Harbeck-Weber C; Biggs BK, 2022, 'Excessive Postural Tachycardia and Postural Orthostatic Tachycardia Syndrome in Youth: Associations With Distress, Impairment, Health Behaviors, and Medication Recommendations', JOURNAL OF CHILD NEUROLOGY, 37, pp. 599 - 608, http://dx.doi.org/10.1177/08830738221078410

Zahra E; Chen R; Nielsen S; Tran AD; Santo T; Degenhardt L; Farrell M; Byrne J; Ali R; Larance B, 2022, 'Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients', Drug and Alcohol Review, 41, pp. 841 - 850, http://dx.doi.org/10.1111/dar.13437

Chaillon A; Bharat C; Stone J; Jones N; Degenhardt L; Larney S; Farrell M; Vickerman P; Hickman M; Martin NK; Bórquez A, 2022, 'Modeling the population-level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia', Addiction, 117, pp. 1338 - 1352, http://dx.doi.org/10.1111/add.15736

Krausz M; Westenberg JN; Tsang V; Suen J; Ignaszewski MJ; Mathew N; Azar P; Cabanis M; Elsner J; Vogel M; Spijkerman R; Orsolini L; Vo D; Moore E; Moe J; Strasser J; Köck P; Marian C; Dürsteler KM; Backmund M; Röhrig J; Post M; Haltmayer H; Wladika W; Trabi T; Muller C; Rechberger G; Teesson M; Farrell M; Christie G; Merry S; Mamdouh M; Alinksy R; Levy S; Fishman M; Rosenthal R; Jang K; Choi F, 2022, 'Towards an International Consensus on the Prevention, Treatment, and Management of High-Risk Substance Use and Overdose among Youth', Medicina (Lithuania), 58, http://dx.doi.org/10.3390/medicina58040539

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Warfield SC; Bharat C; Bossarte RM; DePhilippis D; Farrell M; Hoover M; Larney S; Marshalek P; McKetin R; Degenhardt L, 2022, 'Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109310

Ji YD; McKinley SK; Farrell M; Hemingway M; Qadan M; Saillant N; Phitayakorn R, 2022, 'Operating Room Staff Perceptions of Medical Students', JOURNAL OF SURGICAL EDUCATION, 79, pp. 370 - 382, http://dx.doi.org/10.1016/j.jsurg.2021.10.011

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Farrell M; Shahbazi J; Byrne M; Grebely J; Lintzeris N; Chambers M; Larance B; Ali R; Nielsen S; Dunlop A; Dore GJ; McDonough M; Montebello M; Nicholas T; Weiss R; Rodgers C; Cook J; Degenhardt L, 2022, 'Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence', International Journal of Drug Policy, 100, http://dx.doi.org/10.1016/j.drugpo.2021.103492

Weatherburn D; Darke S; Zahra E; Farrell M, 2022, 'Who would try (or use more) cannabis if it were legal?', Drug and Alcohol Review, 41, pp. 386 - 395, http://dx.doi.org/10.1111/dar.13360

Bosworth RJ; Borschmann R; Altice FL; Kinner SA; Dolan K; Farrell M, 2022, 'HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review', International Journal of Prisoner Health, 18, pp. 66 - 82, http://dx.doi.org/10.1108/IJPH-02-2021-0018

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Mammen K; Mills L; Deacon RM; Bruno R; Dunlop A; Holmes J; Luksza J; Shakeshaft A; Farrell M; Lintzeris N, 2022, 'Determining clinical cutoff scores for the Australian Treatment Outcomes Profile psychological health, physical health and quality of life questions', Drug and Alcohol Review, 41, pp. 106 - 113, http://dx.doi.org/10.1111/dar.13346

Tran AD; Chen R; Nielsen S; Zahra E; Degenhardt L; Santo T; Farrell M; Larance B, 2022, 'Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions', International Journal of Drug Policy, 99, http://dx.doi.org/10.1016/j.drugpo.2021.103472

Acheson LS; Williams BH; Farrell M; McKetin R; Ezard N; Siefried KJ, 2022, 'Pharmacological treatment for methamphetamine withdrawal: A systematic review and meta-analysis of randomised controlled trials', Drug and Alcohol Review, 42, http://dx.doi.org/10.1111/dar.13511

Darke S; Banister S; Farrell M; Duflou J; Lappin J, 2021, '‘Synthetic cannabis’: A dangerous misnomer', International Journal of Drug Policy, 98, pp. 103396, http://dx.doi.org/10.1016/j.drugpo.2021.103396

Yuen WS; Bruno R; Chan GCK; McCambridge J; Slade T; Clare PJ; Aiken A; Kypri K; Hutchinson D; McBride N; Boland V; Upton E; Farrell M; Mattick RP; Peacock A; Peacock A, 2021, 'The experience of physiological and psychosocial alcohol-related harms across adolescence and its association with alcohol use disorder in early adulthood: A prospective cohort study', Alcoholism: Clinical and Experimental Research, 45, pp. 2518 - 2527, http://dx.doi.org/10.1111/acer.14726

Chrzanowska A; Man N; Darke S; Degenhardt L; Farrell M; Moran L; Peacock A, 2021, 'Unintentional and intentional drug poisoning deaths, Australia, 2012–2016: Drug pattern profile and demographic characteristics', Drug and Alcohol Dependence, 229, http://dx.doi.org/10.1016/j.drugalcdep.2021.109112

Courtney RJ; Tutka P; Farrell M, 2021, 'The Effect of Cytisine vs Varenicline on Smoking Cessation - Reply', JAMA - Journal of the American Medical Association, 326, pp. 1872 - 1873, http://dx.doi.org/10.1001/jama.2021.16064

Quinn B; Ward B; Agius PA; Jenkinson R; Hickman M; Sutton K; Hall C; McKetin R; Farrell M; Cossar R; Dietze PM, 2021, 'A prospective cohort of people who use methamphetamine in Melbourne and non-metropolitan Victoria, Australia: Baseline characteristics and correlates of methamphetamine dependence', Drug and Alcohol Review, 40, pp. 1239 - 1248, http://dx.doi.org/10.1111/dar.13194

Farrell M; Griffiths K, 2021, 'APSAD 2021 Conference, 7-10 November 2021, Virtual', Drug and alcohol review, 40, pp. S4 - S154, http://dx.doi.org/10.1111/dar.13384

McKetin R; Sutherland R; Peacock A; Farrell M; Degenhardt L, 2021, 'Patterns of smoking and injecting methamphetamine and their association with health and social outcomes', Drug and Alcohol Review, 40, pp. 1256 - 1265, http://dx.doi.org/10.1111/dar.13364

Farrell MP, 2021, 'The Faces in Einstein's Looking-Glass Self', CONTEMPORARY SOCIOLOGY-A JOURNAL OF REVIEWS, 50, pp. 470 - 472, http://dx.doi.org/10.1177/00943061211050045d

Bharat C; Degenhardt L; Dobbins T; Larney S; Farrell M; Barbieri S, 2021, 'Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment', Drug and Alcohol Dependence, 228, http://dx.doi.org/10.1016/j.drugalcdep.2021.109091

Hall W; Farrell M, 2021, 'What can we learn from the history of research on psychedelic drugs in the addictions?', Addiction, 116, pp. 2936 - 2938, http://dx.doi.org/10.1111/add.15560

Lewer D; Eastwood B; White M; Brothers TD; McCusker M; Copeland C; Farrell M; Petersen I, 2021, 'Fatal opioid overdoses during and shortly after hospital admissions in England: A casecrossover study', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003759

Bargeron L; Farrell M, 2021, 'The Price Effect of Stock Repurchases: Evidence from Dual Class Firms', MANAGEMENT SCIENCE, 67, http://dx.doi.org/10.1287/mnsc.2021.4066

Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L, 2021, 'Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis', JAMA Psychiatry, 78, pp. 979 - 993, http://dx.doi.org/10.1001/jamapsychiatry.2021.0976

Man N; Chrzanowska A; Price O; Bruno R; Dietze PM; Sisson SA; Degenhardt L; Salom C; Morris L; Farrell M; Peacock A, 2021, 'Trends in cocaine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, 40, pp. 946 - 956, http://dx.doi.org/10.1111/dar.13252

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Yuen WS; Chan G; Bruno R; Clare PJ; Aiken A; Mattick R; Farrell M; Kypri K; Slade T; Hutchinson D; McBride N; McCambridge J; Boland V; Peacock A; Peacock A, 2021, 'Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood', Addiction, 116, pp. 2039 - 2048, http://dx.doi.org/10.1111/add.15415

Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M, 2021, 'Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 326, pp. 56 - 64, http://dx.doi.org/10.1001/jama.2021.7621

Huang H; Sequoia K; Yamaguchi M; Boehm KJ; Engelhorn K; Walker J; Elsner F; Tomlin J; Farrell M; Fontes CJ; Colgan JP, 2021, 'Improved x-ray mass attenuation coefficient (opacity) measurements for Fe, Ni and Au', Journal of Physics B: Atomic, Molecular and Optical Physics, 54, pp. 115003 - 115003, http://dx.doi.org/10.1088/1361-6455/abf01c

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N, 2021, 'Assessing the concurrent validity, inter-rater reliability and test–re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations', Addiction, 116, pp. 1245 - 1255, http://dx.doi.org/10.1111/add.15331

Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Maher L; Harrod M; Farrell M; Wilson D, 2021, 'A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria', Transfusion Medicine and Hemotherapy, http://dx.doi.org/10.1159/000509027

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Jones NR; Nielsen S; Farrell M; Ali R; Gill A; Larney S; Degenhardt L, 2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y, 2020, 'Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis', Neurology, 95, pp. E2610 - E2621, http://dx.doi.org/10.1212/WNL.0000000000010752

Back to profile page